New AI technology uses voice analysis to detect undiagnosed type 2 diabetes

New research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), highlights the potential of using voice analysis to detect undiagnosed type 2 diabetes (T2D) cases.

Merck’s $1.4B cyberattack suit goes to New Jersey Supreme Court

Merck’s insurance battle over $1.4 billion in alleged losses from a 2017 malware attack is now headed to New Jersey Supreme Court following an appellate

July 27, 2023

Azithromycin at Routine Visits Fails to Prevent Infant Deaths in Africa

Azithromycin did not prevent infant deaths when provided at routine healthcare visits in the West African country of Burkina Faso, a randomized controlled trial demonstrated.

January 18, 2024

Spironolactone Misses the Mark in Acute MI Without HF

CHICAGO — A mineralocorticoid receptor antagonist (MRA) was unable to further improve 3-year outcomes of acute myocardial infarction (MI) in the modern era, based on

November 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.